Nothing Special   »   [go: up one dir, main page]

FR2682598B1 - Compositions pharmaceutiques de peptides et procedes pour leur preparation. - Google Patents

Compositions pharmaceutiques de peptides et procedes pour leur preparation.

Info

Publication number
FR2682598B1
FR2682598B1 FR9208675A FR9208675A FR2682598B1 FR 2682598 B1 FR2682598 B1 FR 2682598B1 FR 9208675 A FR9208675 A FR 9208675A FR 9208675 A FR9208675 A FR 9208675A FR 2682598 B1 FR2682598 B1 FR 2682598B1
Authority
FR
France
Prior art keywords
peptides
preparation
methods
pharmaceutical compositions
pharmaceutical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR9208675A
Other languages
English (en)
Other versions
FR2682598A1 (fr
Inventor
Moise Azria
Gert Fricker
Jacky Vonderscher
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sandoz AG
Original Assignee
Sandoz AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB919115202A external-priority patent/GB9115202D0/en
Priority claimed from GB929200748A external-priority patent/GB9200748D0/en
Application filed by Sandoz AG filed Critical Sandoz AG
Publication of FR2682598A1 publication Critical patent/FR2682598A1/fr
Application granted granted Critical
Publication of FR2682598B1 publication Critical patent/FR2682598B1/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/28—Steroids, e.g. cholesterol, bile acids or glycyrrhetinic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/23—Calcitonins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Organic Chemistry (AREA)
  • Rheumatology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
FR9208675A 1991-07-15 1992-07-13 Compositions pharmaceutiques de peptides et procedes pour leur preparation. Expired - Fee Related FR2682598B1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB919115202A GB9115202D0 (en) 1991-07-15 1991-07-15 Improvements relating to organic compounds
GB929200748A GB9200748D0 (en) 1992-01-14 1992-01-14 Improvements relating to organic compounds

Publications (2)

Publication Number Publication Date
FR2682598A1 FR2682598A1 (fr) 1993-04-23
FR2682598B1 true FR2682598B1 (fr) 1996-04-05

Family

ID=26299234

Family Applications (1)

Application Number Title Priority Date Filing Date
FR9208675A Expired - Fee Related FR2682598B1 (fr) 1991-07-15 1992-07-13 Compositions pharmaceutiques de peptides et procedes pour leur preparation.

Country Status (7)

Country Link
JP (1) JPH05194260A (fr)
BE (1) BE1007752A5 (fr)
CH (1) CH685600A5 (fr)
DE (1) DE4222647A1 (fr)
FR (1) FR2682598B1 (fr)
GB (1) GB2257908B (fr)
IT (1) IT1263222B (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5698672A (en) * 1995-04-04 1997-12-16 Zymogenetics, Inc. Synthetic calcitonin mimetics
US5698521A (en) * 1995-04-04 1997-12-16 Zymogenetics, Inc. Native calcitonin mimetics
AU1808897A (en) * 1995-12-13 1997-07-03 Dullatur Limited A calcitonin preparation
GB9614235D0 (en) * 1996-07-06 1996-09-04 Danbiosyst Uk Composition for enhanced uptake of polar drugs from mucosal surfaces
US6228836B1 (en) 1997-04-14 2001-05-08 Mitsubishi-Tokyo Pharmaceuticals, Inc. Permucous preparation
US7030082B2 (en) * 2001-09-07 2006-04-18 Nobex Corporation Pharmaceutical compositions of drug-oligomer conjugates and methods of treating disease therewith

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4151276A (en) * 1975-05-12 1979-04-24 Armour Pharmaceutical Company Method of suppressing gastric acid secretion by the oral administration of calcitonin
GB2127689B (en) * 1982-10-05 1986-07-09 Sandoz Ltd Calcitonin inhalation compositions
IL70489A0 (en) * 1982-12-29 1984-03-30 Armour Pharma Pharmaceutical compositions containing calcitonin
JPS59163313A (ja) * 1983-03-09 1984-09-14 Teijin Ltd 経鼻投与用ペプチドホルモン類組成物
JPS61194034A (ja) * 1985-02-25 1986-08-28 Teijin Ltd 経鼻投与用粉末状組成物
HU203204B (en) * 1987-09-15 1991-06-28 Sandoz Ag Process for producing suppository containing calcitonin and taurocholic acid
GB2218102B (en) * 1988-04-08 1992-09-16 Sandoz Ltd Calcitonin peptide derivatives
HU206367B (en) * 1988-04-30 1992-10-28 Sandoz Ag Process for producing acid addition salts of steroid carboxylic acid-amidated taurine and glycine, as well as pharmaceutical compositions comprising such salts
JP2911496B2 (ja) * 1989-09-11 1999-06-23 帝國製薬株式会社 生理活性ポリペプチド含有高吸収性経膣剤
EP0432431B1 (fr) * 1989-11-16 1993-06-16 PHIDEA S.p.A. Composition liquide pharmaceutique pour application nasale contenant un polypeptide comme ingrédient actif

Also Published As

Publication number Publication date
GB2257908A (en) 1993-01-27
JPH05194260A (ja) 1993-08-03
DE4222647A1 (de) 1993-01-21
FR2682598A1 (fr) 1993-04-23
ITRM920535A1 (it) 1994-01-14
BE1007752A5 (fr) 1995-10-17
GB2257908B (en) 1995-12-20
IT1263222B (it) 1996-08-05
ITRM920535A0 (it) 1992-07-14
GB9214830D0 (en) 1992-08-26
CH685600A5 (de) 1995-08-31

Similar Documents

Publication Publication Date Title
MA26443A1 (fr) Aralkyl- et aralkylidene-lactames et -imides heterocycliques, procedes pour leur preparation et compositions pharmaceutiques les contenant
MC2077A1 (fr) Derives benzoiques et phenylacetiques,procedes pour leur preparation et compositions pharmaceutiques en contenant
EP0573423A4 (en) Methods and preparations of stable, deodorized oils and pharmaceutical compositions thereof
DK0539319T3 (da) Farmaceutisk cyclosporinpræparat
FR2530625B1 (fr) Derives d'indole, procedes pour leur preparation et compositions pharmaceutiques les contenant
DZ2595A1 (fr) Associations de compositions pharmaceutiques d'atorvastatine et d'agents antihypertensifs et procédépour leur préparation.
FI973039A0 (fi) Uusia farnesyylitransferaasin inhibiittoreita, niiden valmistus ja niitä sisältäviä farmaseuttisia koostumuksia
EE03177B1 (et) Heterobitsüklilised ühendid, nende saamismeetod ja nimetatud ühendeid sisaldavad farmatseutilised kompositsioonid
FR2742751B1 (fr) Nouveaux taxoides, leur preparation et les compositions pharmaceutiques qui les contiennent
FR2732223B1 (fr) Composition pharmaceutique pour administration transdermique
FR2636532B1 (fr) Compositions pharmaceutiques
MA26422A1 (fr) Derives de quinoxalinedone, procedes et intermediaires pour leur preparation, et compositions pharmaceutiques les contenant.
IL122705A (en) 2-(4-Susbstituted)-benzylamino-2-methyl-propanamide derivatives their preparation and pharmaceutical compositions containing them
FR2732968B1 (fr) Nouveaux taxoides, leur preparation et les compositions pharmaceutiques qui les contiennent
FR2757166B1 (fr) Derives du pyrrole, leur preparation et les compositions pharmaceutiques qui les contiennent
FR2732342B1 (fr) Nouveaux taxoides, leur preparation et les compositions pharmaceutiques qui les contiennent
FR2682598B1 (fr) Compositions pharmaceutiques de peptides et procedes pour leur preparation.
ZA933426B (en) New dihydroxybenzylamine derivatives their preparation and pharmaceutical compositions which contain them
FR2664814B1 (fr) Compositions pharmaceutiques solides et leur procede de preparation.
NO951933L (no) Farmasöytiske formuleringer av ibuprofen
ITMI913510A1 (it) Composizioni farmaceutiche contenenti progesterone ad elevata biodisponibilita'
BR9307182A (pt) Composições farmacêuticas de 2-oxindol-1-carboxamidas 3-substituídas
FR2751332B1 (fr) Derives d'oxopyrrolopyrrole, procede pour leur preparation, compositions pharmaceutiques les contenant et leur utilisation
FR2677355B1 (fr) Nouveaux derives de l'oxazole, leur preparation et les compositions pharmaceutiques qui les contiennent.
FR2742753B1 (fr) Nouveaux taxoides, leur preparation et les compositions pharmaceutiques qui les contiennent

Legal Events

Date Code Title Description
ST Notification of lapse